SILVERARC CAPITAL MANAGEMENT, LLC – BioCryst Pharmaceuticals, Inc. Transaction History
SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:
$2.35M
portfolio value
SILVERARC CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +248.65% | 133.08K shares | 1.78M | $12.6 | 186.60K |
| Q2 2022 | share | Decrease | -47.75% | -48.90K shares | 369K | $10.58 | 53.52K |
| Q1 2022 | share | Increase | 0.00% | 102.42K shares | 197K | $16.26 | 102.42K |
| Q1 2021 | share | Decrease | -100.00% | -110K shares | -820K | $10.17 | 0 |
| Q4 2020 | share | Increase | 0.00% | 110K shares | 820K | $7.45 | 110K |